Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice

Nature Medicine

Volumn 5, Issue 11, 1999, Pages 1285-1291

  Aszterbaum, Michelle ^a   Epstein, John ^a   Anthony, Oro ^b   Douglas, Vanja ^a   Leboit, Philip E ^a   Scott, Matthew P ^c   Epstein Jr , Ervin H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL CELL CARCINOMA; BLASTOMA; CANCER GROWTH; CANCER SIZE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE MUTATION; HEDGEHOG; HEMIDESMOSOME; HETEROZYGOSITY LOSS; HETEROZYGOTE; IMMUNOHISTOLOGY; IONIZING RADIATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; REPORTER GENE; ULTRAVIOLET RADIATION;

ANIMALS; CARCINOMA, BASAL CELL; CELL DIVISION; HETEROZYGOTE; HUMANS; LAC OPERON; LOSS OF HETEROZYGOSITY; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; NEOPLASMS, BASAL CELL; NEOPLASMS, RADIATION-INDUCED; ONCOGENE PROTEINS; RADIATION, IONIZING; RECEPTORS, CELL SURFACE; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; ULTRAVIOLET RAYS;

EID: 0032694528     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/15242     Document Type: Article

References (40)

1. Miller, D.L. & Weinstock, M.A. Non-melanoma skin cancer in the United States: incidence. J. Am. Acad. Dermatol. 30, 774-778 (1994).
2. Hahn, H. et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85, 841-851 (1996).
3. Johnson, R.L. et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272, 1668-1671 (1996).
4. Vorechovsky, I., Unden, A.B., Sandstedt B., Toftgard, R. & Stahle-Backdahl, M. Trichoepitheliomas contain somatic mutations in the overexpressed PTCH gene: support for a gatekeeper mechanism in skin tumorigenesis. Cancer Res. 57, 4677-4681 (1997).
5. Raffel, C. et al. Sporadic medulloblastomas contain PTCH mutations. Cancer Res. 57, 842-845 (1997).
6. Xie, J. et al. Mutations of the PATCHED gene in several types of sporadic extracutaneous tumors. Cancer Res 57, 2369-2372, (1997).
7. Gailani, M.R. et al. The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nature Genet. 14, 78-81 (1996).
8. Kallassy, M. et al. Patched (ptch)-associated preferential expression of smoothened (smoh) in human basal cell carcinoma of the skin. Cancer Res. 57, 4731-4735 (1997).
9. Dahmane, N., Lee, J., Robins, P., Heller, P. & Ruiz i Altaba, A. Activation of the transcription factor Gli1 and the sonic hedgehog signalling pathway in skin tumours. Nature 389, 876-880 (1997).
10. Green, J., Leigh, I.M., Poulsom R., Quinn, A.C. Basal cell carcinoma development is associated with induction of the expression of the transcription factor Gli-1 Br. J. Dermatol. 139, 911-915 (1998).
11. Bogovski, P. in Tumours of the Mouse. Pathology of Tumours in Laboratory Animals Vol. 2 (eds. Turusov, V.S. & Mohr, U.) 11-12 (International Agency for Research on Cancer, Lyon, 1994).
12. Oro, A.E. et al. Basal cell carcinomas in mice overexpressing sonic hedgehog Science 276, 817-821 (1997).
13. Xie, J. et al. Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature 391, 90-92 (1998).
14. Goodrich, L.V., Milenkovic, L., Higgins, K.M., & Scott, M.P. Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 277, 1109-1113 (1997).
15. Hahn, H. et al. Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome. Nature Med. 4, 619-622 (1998).
16. Walsh, N., Ackerman, A.B. Infundibulocystic basal cell carcinoma: a newly described variant. Mod. Path. 3, 599-608 (1990).
17. Gorlin, R.J. Nevoid basal cell carcinoma syndrome. Medicine 66, 98-109 (1987).
18. Hashimoto, K., Howell, J.B., Yamanishi, Y., Holubar, K. & Bernhard, R. Electron microscopic studies of palmar and plantar pits of nevoid basal cell epithelioma. J. Invest. Dermatol. 59, 380-393 (1972).
19. Karagas, M.R. et al. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. J. Natl. Cancer Inst. 88, 1848-1852 (1996).
20. O'Malley, S. et al. Multiple neoplasms following craniospinal irradiation for medulloblastoma in a patient with nevoid basal cell carcinoma syndrome. J. Neurosurg. 86, 286-288 (1997).
21. Miller, S.J., Tung-Tien, S. & Lavker, R.M. Hair follicles, stem cells, and skin cancer. J. Invest. Dermatol. 100, 288S-294S (1993).
22. Markey, A.C., Lane, E.B., MacDonald, D.M. & Leigh, I.M. Keratin expression in basal cell carcinomas. Br. J. Dermatol. 126, 154-160 (1992).
23. Fairley, J.A., Heintz, P.W., Neuburg, M., Diaz, L.A. & Giudice, G.J. Expression pattern of the bullous pemphigoid-180 antigen in normal and neoplastic epithelia. Br. J. Dermatol. 133, 385-391 (1995).
24. Bahadoran, P. et al. Altered expression of the hemidesmosome-anchoring filament complex proteins in basal cell carcinoma: possible role in the origin of peritumoral lacunae. Br. J. Dermatol. 136, 35-42 (1997).
25. Smoller, B.R., Van de Rijn, M., Lebrun, D. & Warnke, R.A. Bcl-2 expression reliably distinguishes trichoepitheliomas from basal cell carcinomas. Br. J. Dermatol. 131, 28-31 (1994).
26. Bonifas, J.M., Bare, J.W., Kerschmann, R.L., Master, S.P. & Epstein, E.H. Jr. Parental origin of chromosome 9q22.3-q31 lost in basal cell carcinomas from basal cell nevus syndrome patients. Hum. Mol. Genet. 3, 447-448 (1994).
27. Van der Riet, P. et al. Progression of basal cell carcinoma through loss of chromosome 9 and inactivation of a single p53 allele. Cancer Res. 54, 25-27 (1994).
28. Gailani, M.R. et al. Relationship between sunlight exposure and a key genetic alteration in basal cell carcinoma. J. Natl. Cancer Inst. 88, 349-354 (1996).
29. Grando, S.A. et al. Nodular basal cell carcinoma in vivo vs. in vitro. Arch. Dermatol. 132, 1185-1193 (1996).
30. Nishigori, C., Yarosh, D.B., Danawho, C. & Kripke, M.L. The immune system in ultraviolet carcinogenesis. J. Invest. Dermatol. Symp. Proc. 1, 143-146 (1996).
31. Della Porta, G., Terracini, B., Dammert, K. & Shubik, P. Histopathology of tumors induced in mice treated with polyoxyethylene sorbitan monostearate. J. Natl. Cancer Inst. 25, 573-605 (1960).
32. Quinn, A.G., Campbell, C., Healy, E. & Rees, J.L. Chromosome 9 allele loss occurs in both basal and squamous cell carcinomas of the skin. J. Invest. Dermatol. 102, 300-303 (1994).
33. Epstein, J.H. Comparison of the carcinogenic and cocarcinogenic effects of ultraviolet light on hairless mice. J. Natl. Cancer Inst. 34, 741 -745 (1965).
34. Epstein, J.H. in Models in Dermatology Vol 2 (eds. Maibach, H. & Lowe, N.J.) 303-312 (Karger, Basel, 1985).
35. Guo, L., Yu, Q.-C. & Fuchs, E. Targeting expression of keratinocyte growth factor to keratinocytes elicits striking changes in epithelial differentiation in transgenic mice. EMBO J. 12, 973-986 (1993).
36. Liu, Z. et al. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J. Clin. Invest. 92, 2480-2488 (1993).
37. Aberdam, D. et al. Developmental expression of nicein adhesion protein (laminin 5) subunits suggests multiple morphogenic roles. Cell Adhes. and Commun. 2, 115-129 (1994).
38. Krajewski, S. et al. Immunohistochemical determination of in vivo distribution of bax, a dominant inhibitor of bcl-2. Am. J. Path. 145, 1323-1336 (1994).
39. Kress, S. et al. Carcinogen-specific mutational pattern in the p53 gene in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin. Cancer Res. 52, 6400-6403 (1992).
40. Garrigue, J.L. et al. Optimization of the mouse ear swelling test for in vivo and in vitro studies of weak contact sensitizers. Contact Dermatitis 30, 231-237 (1994).